KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Merck (MRK) Leases (2019 - 2025)

Merck has reported Leases over the past 7 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly Leases rose 10.0% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 10.0% year-over-year, with the annual reading at $1.5 billion for FY2025, 10.0% up from the prior year.
  • Leases was $1.5 billion for Q4 2025 at Merck, up from $1.4 billion in the prior quarter.
  • Over five years, Leases peaked at $1.6 billion in Q4 2021 and troughed at $1.3 billion in Q4 2022.
  • The 5-year median for Leases is $1.4 billion (2023), against an average of $1.4 billion.
  • Year-over-year, Leases dropped 15.13% in 2022 and then increased 10.0% in 2025.
  • A 5-year view of Leases shows it stood at $1.6 billion in 2021, then dropped by 15.13% to $1.3 billion in 2022, then rose by 6.76% to $1.4 billion in 2023, then decreased by 4.66% to $1.4 billion in 2024, then increased by 10.0% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Leases are $1.5 billion (Q4 2025), $1.4 billion (Q4 2024), and $1.4 billion (Q4 2023).